Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Economic evaluation in evidence-based practice.

Marko B Lens1, Martin Dawes

  • 1Centre for Evidence-Based Medicine, University of Oxford, Department of Clinical Medicine, The Oxford Radcliffe NHS Trust, UK. markolens@aol.com

Expert Opinion on Pharmacotherapy
|August 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A feasibility study to collect three generation family histories using a patient completed questionnaire provided by a family physician.

Journal of community genetics·2026
Same author

Are Canadian Clinical Practice Guidelines Accounting for Adults With Multiple Chronic Diseases? A Systematic Review.

Journal of evaluation in clinical practice·2025
Same author

Preventive Lipid-Lowering Therapy and Interactions With Health Care in Patients Who Develop Premature Coronary Artery Disease.

JACC. Advances·2025
Same author

STRIPE partners in precision medicine series: provider perspective.

The pharmacogenomics journal·2024
Same author

Home Blood Pressure Telemonitoring Technology for Patients With Asymptomatic Elevated Blood Pressure Discharged From the Emergency Department: Pilot Study.

JMIR formative research·2023
Same author

Improving prescribing: a feasibility study of pharmacogenetic testing with clinical decision support in primary healthcare in Singapore.

Family practice·2022
Same journal

Pharmacotherapeutic interventions for pediatric ulcerative colitis.

Expert opinion on pharmacotherapy·2026
Same journal

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal.

Expert opinion on pharmacotherapy·2026
Same journal

Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder.

Expert opinion on pharmacotherapy·2026
Same journal

GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Expert opinion on pharmacotherapy·2026
Same journal

Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia.

Expert opinion on pharmacotherapy·2026
Same journal

Current advances in pharmacotherapeutic strategies for the treatment of complicated intra-abdominal infections.

Expert opinion on pharmacotherapy·2026
See all related articles

Economic evaluations of healthcare interventions are crucial but often flawed. This article outlines economic analysis types, offering a framework for evaluating these essential health technology assessments.

Area of Science:

  • Health Economics
  • Health Services Research
  • Technology Assessment

Background:

  • Economic evaluation of healthcare interventions and technologies is vital for modern healthcare systems.
  • There is a rising demand for data on the economic benefits of healthcare technologies.
  • Reviews reveal significant methodological flaws in numerous health economic analyses.

Purpose of the Study:

  • To describe the main types of economic analyses used in healthcare.
  • To provide a framework for evaluating economic health technology assessments.
  • To address the need for standardized guidance in multinational economic evaluations.

Main Methods:

  • Descriptive overview of common economic analysis types.
  • Discussion of methodological challenges in health economic evaluations.

Related Experiment Videos

  • Presentation of a framework for evaluating economic assessments.

    • Main Results:

    • Identified various types of economic analyses in healthcare.
    • Highlighted prevalent methodological limitations in published studies.
    • Proposed a structured approach for evaluating economic evidence.

    Conclusions:

    • Standardized guidance for multinational economic evaluations is lacking.
    • A clear framework is needed to assess the quality of economic evaluations.
    • Improved methodology and reporting are essential for reliable health economic research.